Skip to main content
. 2021 Aug 18;118(35):e2104640118. doi: 10.1073/pnas.2104640118

Fig. 3.

Fig. 3.

Reduction in ICU occupancy using the optimized second-dose delay strategy compared with the standard delay strategy. The graph shows the predicted reduction in ICU admissions when the first-dose efficacy is varied from 0 to 80% in 5% increments and is normalized to the baseline strategy of 4 wk between doses.